About US
Contact us
-
Big Pharma including Pfizer, Sanofi meet to fight noncommunicable diseases around the worldBig pharma is coming together to advance noncommunicable disease care in the developing world. An initiative called Access Acceleratedbrings together more than 20 of the largest pharma companies to ad2017/9/25
-
For Endo's new campaign partner, golf pro Herron, Dupuytren's is all in the familyPGA golf pro Tim Herron has more than passing knowledge of hand deformity Dupuytren’s contracture: He, his father and his sister all have the condition. So he reached out to Endo Pharmaceuticals, make2017/9/25
-
French police visit Merck KGaA offices in inquiry into Levothyrox complaintsFrench police searched the French offices of Merck KGaA as consumer complaints have piled up over a formulation change the drugmaker made to thyroid drug Euthyrox at the request of French regulators.2017/9/22
-
Allergan CEO Saunders defends Restasis deal by calling for review of patent challenge processOne day after Allergan's tribal licensing deal on Restasis drew attention from a powerful senator, the drugmaker sought to further justify its agreement by attacking the patent review system. In a T2017/9/22
-
FDA’s Gottlieb pushes new generics rules to encourage price competitionThe FDA’s role in drug development has always been to green light safe and effective drugs—not to influence how companies price them. But that was before consumers protested price hikes on Mylan’s Epi2017/9/21
-
Asthma’s a real bear in Boehringer Ingelheim’s new TV campaign for Spiriva RespimatWant to know what asthma feels like? Try a crushing bear hug. That’s what patients told Boehringer Ingelheim, informing its latest campaign for Spiriva Respimat as a treatment for asthma. In new TV2017/9/21
-
Judge tosses U.S. lawsuit against GSK from private eyes imprisoned in ChinaGlaxoSmithKline has worked hard to put 2013’s China bribery scandal behind it. And a U.S. judge just gave it an assist in that department. U.S. District Judge Nitza Quiñones Alejandro in Phi2017/9/20
-
Endo, feeling the pricing squeeze, could be the next generics player on the hunt for M&A: analystLate last month, reports said Impax Labs may be looking to bulk up in the face of industry-wide generics pricing pressure with a deal for Amneal. And at least one analyst thinks it may make sense for2017/9/20
-
Sanofi tasks insider Stefan Oelrich with a tough job: Growing diabetes and PraluentSanofi has turned to one of its own to take the reins of its global diabetes and cardiovascular business. Stefan Oelrich, who’s been leading that operation in North America since July, is moving up to2017/9/19
-
Promising Ebola vaccines from Merck, Johnson & Johnson win BARDA fundingEven though the devastating Ebola outbreak in West Africa has ended, U.S. officials and top pharmas aren't letting up on their vaccine development efforts against the virus. Now, the U.S. government2017/9/19